Guru Ownership Trend
Guru Analysis for Amneal Pharmaceuticals, Inc. (AMRX)
Amneal Pharmaceuticals, Inc. (AMRX), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $15.42 M.
Top institutional holders include Cliff Asness and Renaissance Technologies (RenTech).
Institutional sentiment is currently Bullish. This is evidenced by a $407,873.01 net inflow during the quarter.
Recent activity highlights Renaissance Technologies (RenTech) who dramatically increased their stake. Conversely, Cliff Asness reduced exposure by 17.3%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Amneal Pharmaceuticals, Inc. (AMRX)
Major holders include Cliff Asness ($10.75 M), Renaissance Technologies (RenTech) ($3.44 M), Steven Cohen ($970,845). According to the latest reported data, 4 tracked investment managers collectively hold approximately 1.24 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $407,873.01, with 3 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 2 fully exited AMRX. The total reported sell value was $3.83 M.
Yes, 1 managers opened new positions in AMRX, and 2 increased their existing holdings. The total reported buy value was $4.24 M.